James Welsh

1.8k total citations
16 papers, 439 citations indexed

About

James Welsh is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, James Welsh has authored 16 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Surgery. Recurrent topics in James Welsh's work include Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (6 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). James Welsh is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (6 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). James Welsh collaborates with scholars based in United States, China and Belgium. James Welsh's co-authors include Daniel R. Gomez, Joe Y. Chang, Peter Balter, Zhongxing Liao, Eric D. Brooks, Mary Frances McAleer, Melenda Jeter, Bing Sun, Stephen M. Hahn and Michael S. O’Reilly and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

James Welsh

15 papers receiving 431 citations

Peers

James Welsh

PRM

RNMI

RADIA

ONCOL

SURGE

Morikatsu Wada Australia

A. Miyakawa Japan

Carlo Furlan Italy

Daijiro Kobayashi Japan

Prashant Gabani United States

Atsushi Musha Japan

Jaymin Jhaveri United States

Tingyong Fan China

Debora Beldì Italy

P. Dickinson United Kingdom

Morikatsu Wada Australia

James Welsh

242 ×0.8

PRM

157 ×1.0

RNMI

123 ×0.9

RADIA

91 ×1.0

ONCOL

126 ×1.9

SURGE

Citations per year, relative to James Welsh James Welsh (= 1×) peers Morikatsu Wada

Countries citing papers authored by James Welsh

Since Specialization

Citations

This map shows the geographic impact of James Welsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Welsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Welsh more than expected).

Fields of papers citing papers by James Welsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Welsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Welsh. The network helps show where James Welsh may publish in the future.

Co-authorship network of co-authors of James Welsh

This figure shows the co-authorship network connecting the top 25 collaborators of James Welsh. A scholar is included among the top collaborators of James Welsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Welsh. James Welsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Son, Ji Y., Cheng‐En Hsieh, Heather Lin, et al.. (2022). Inhibition of the CD47-SIRPα axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data. Frontiers in Immunology. 13. 1027235–1027235. 31 indexed citations

Welsh, James, Hampartsoum B. Barsoumian, Jane P. F. Bai, et al.. (2021). 376 Radiation sub-study to characterize safety and tolerability of low-dose radiation in combination with afami-cel in patients with advanced cancers (NCT03132922). SHILAP Revista de lepidopterología. A407–A407. 2 indexed citations

Mesko, Shane, Matthew S. Ning, Vivek Verma, et al.. (2020). Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis. International Journal of Radiation Oncology*Biology*Physics. 107(5). 897–908.

Benveniste, Marcelo F., James Welsh, Chitra Viswanathan, et al.. (2018). Lung Cancer. Radiologic Clinics of North America. 56(3). 471–483. 5 indexed citations

Sun, Bing, Eric D. Brooks, Ritsuko Komaki, et al.. (2017). Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial. Journal of Thoracic Oncology. 12(6). 983–992. 52 indexed citations

Fang, Penny, Cameron W. Swanick, Todd A. Pezzi, et al.. (2017). Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer. Practical Radiation Oncology. 7(6). 433–441. 12 indexed citations

Wang, Qifeng, Shouhao Zhou, Laurence E. Court, et al.. (2017). Radiomics predicts clinical outcome in primary gastroesophageal junction adenocarcinoma treated by chemo/radiotherapy and surgery. Physics and Imaging in Radiation Oncology. 3. 37–42. 12 indexed citations

Sun, Bing, Eric D. Brooks, Ritsuko Komaki, et al.. (2017). 7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial. Cancer. 123(16). 3031–3039. 114 indexed citations

Zhao, Lina, Shouhao Zhou, Peter Balter, et al.. (2016). Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 95(4). 1226–1235. 47 indexed citations

10.

Reddy, Jay P., Chad Tang, Ya‐Chen Tina Shih, et al.. (2016). Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non–small-cell Lung Cancer. Clinical Lung Cancer. 18(2). 141–148. 8 indexed citations

11.

Fu, Xiaolong, Kuaile Zhao, Kailiang Wu, et al.. (2014). Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma. Strahlentherapie und Onkologie. 190(11). 979–986. 38 indexed citations

12.

Benveniste, Marcelo F., et al.. (2013). New era of radiotherapy: An update in radiation-induced lung disease. Clinical Radiology. 68(6). e275–e290. 47 indexed citations

13.

Komaki, Ritsuko, George R. Blumenschein, I. Wistuba, et al.. (2011). The Phase II Trial Of Erlotinib And Radiotherapy Following Chemoradiotherapy For Patients With Stage III Non-small Cell Lung Cancer Has Shown A Favorable Response Profile. International Journal of Radiation Oncology*Biology*Physics. 81(2). S591–S592. 1 indexed citations

14.

Nguyen, Nam P., Paul Vos, Howard Lee, et al.. (2008). Impact of Tumor Board Recommendations on Treatment Outcome for Locally Advanced Head and Neck Cancer. Oncology. 75(3-4). 186–191. 30 indexed citations

15.

Welsh, James, Abhay Sanan, Sylvan B. Green, et al.. (2007). GliaSite Brachytherapy Boost as Part of Initial Treatment of Glioblastoma Multiforme: A Retrospective Multi-Institutional Pilot Study. International Journal of Radiation Oncology*Biology*Physics. 68(1). 159–165. 34 indexed citations

16.

Frassica, Deborah A., et al.. (2000). RADIATION THERAPY. Orthopedic Clinics of North America. 31(4). 557–566. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact